Expand DTIL Menu
DTIL MENU

DTIL Latest Press Releases

-- November 21, 2024 --

Precision BioSciences to Participate in Upcoming November Investor Conferences Business Wire 7:01 AM

-- November 15, 2024 --

Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B Business Wire 7:00 AM

-- November 4, 2024 --

Precision BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update Business Wire 7:01 AM

-- October 29, 2024 --

Precision BioSciences to Report Third Quarter Results on November 4, 2024 Business Wire 7:01 AM

-- October 28, 2024 --

Precision BioSciences to Host Virtual Investor Event Highlighting PBGENE-HBV Preclinical Safety Data and Phase 1 Clinical Trial Plans on November 15, 2024 Business Wire 7:01 AM

-- October 24, 2024 --

Precision BioSciences Presents Preclinical Data Highlighting the Capability of ARCUS for High-Efficiency Gene Editing Utilizing Homology-Directed Repair at the ESGCT 31st Annual Congress Business Wire 4:15 PM
Precision BioSciences Receives First Approval of Clinical Trial Application to Initiate PBGENE-HBV First-In-Human Study for the Treatment of Chronic Hepatitis B Business Wire 8:47 AM

-- October 21, 2024 --

Precision BioSciences to Participate in Upcoming Longwood Boston CEO and Guggenheim Healthcare Conferences Business Wire 7:01 AM

-- October 16, 2024 --

Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Congress Business Wire 7:01 AM

-- October 3, 2024 --

Precision BioSciences to Present at the Upcoming H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference Business Wire 7:01 AM

-- September 30, 2024 --

Precision BioSciences Submits First Clinical Trial Applications to Initiate Phase 1 Trial for PBGENE-HBV for the Treatment of Chronic Hepatitis B Business Wire 7:01 AM

-- September 20, 2024 --

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Business Wire 7:01 AM

-- September 12, 2024 --

Precision BioSciences Strengthens Senior Leadership Team Ahead of Anticipated PBGENE-HBV Clinical Execution Business Wire 7:15 AM

-- September 4, 2024 --

Precision BioSciences to Participate in Upcoming H.C. Wainwright 26th Annual Global Healthcare Conference Business Wire 7:01 AM

-- September 3, 2024 --

Precision BioSciences Receives $13 Million in Proceeds from Imugene Convertible Note Maturity as Part of the August 2023 Azer-cel Deal Business Wire 7:01 AM

-- August 13, 2024 --

Sidoti Events, LLC's Virtual August Micro-Cap Conference ACCESSWIRE 9:33 AM

-- August 9, 2024 --

Precision BioSciences Announces Investigational New Drug Clearance by Partner TG Therapeutics for Investigation of Azer-Cel for Multiple Sclerosis Business Wire 7:01 AM

-- August 1, 2024 --

Precision BioSciences Reports Second Quarter 2024 Financial Results and Provides Business Update Business Wire 7:15 AM

-- July 31, 2024 --

Precision BioSciences to Participate in Upcoming August Investor Conferences Business Wire 7:01 AM

-- July 29, 2024 --

Precision BioSciences to Report Second Quarter Results on August 1, 2024 Business Wire 4:15 PM